CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
InterAx Biotech has created PICARD, a lead discovery platform that utilizes systems biology and artificial intelligence to design improved drug candidates. By significantly reducing the need for animal testing and enhancing the predictability of drug success, PICARD aims to streamline the drug development process and l…
InterAx Biotech, a Swiss company and spin-off from the ETH Zürich and the Paul Scherrer Institute, has built PICARD, an innovative and unique lead discovery platform for the design and selection of better drug candidates. PICARD combines a systems biology approach with experimental data and uses artificial intelligence methods to design novel compounds with the desired properties.
This holistic approach differentiates PICARD from technologies now used in the pharmaceutical industry.
Our systems…
INTERAX BIOTECHSA INTERAX BIOTECH LTD
INTERAX BIOTECH AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
